Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Vaccine
Vaccine
Page 9 of 12
Newsletters
The tech-stock bulls are back
By
Research Team
September 16, 2020
Health
China’s controversial emergency-use program for COVID vaccines is going global
By
Crypto Correspondent
September 16, 2020
Newsletters
Is M&A back? Investors hope so, and that’s lifting global stocks
By
Market Analyst
September 15, 2020
Newsletters
A flurry of M&A deals lifts global stocks. Yes, even tech stocks
By
Digital Assets Editor
September 14, 2020
International
AstraZeneca’s COVID-19 vaccine is back on track after getting the green light to resume trials in the U.K.
By
Stephanie Baker
and
Bloomberg
September 13, 2020
Newsletters
The future of the call center
By
David Meyer
and
Alan Murray
September 11, 2020
International
When will a COVID vaccine be ready? The fourth quarter or early 2021, top Chinese vaccine executive says
By
Market Analyst
September 11, 2020
Health
COVID-19 vaccine still on track for later this year despite trial pause, AstraZeneca CEO says
By
Blockchain Reporter
September 10, 2020
Newsletters
Pfizer’s Albert Bourla: Vaccine efforts are improving Big Pharma’s reputation
By
David Meyer
and
Alan Murray
September 10, 2020
Newsletters
Global markets dip as investors again sour on tech stocks
By
Research Team
September 10, 2020
International
Scientists see an upside to AstraZeneca halting its COVID-19 vaccine trial
By
Crypto Correspondent
September 9, 2020
Newsletters
Global stocks climb—and futures jump—after Tuesday’s sell-off
By
Staff Writer
September 9, 2020
Newsletters
Why last week’s great tech sell-off should make investors wary
By
Financial Writer
September 8, 2020
International
A Chinese vaccine maker is injecting employees and their families with its COVID-19 candidate
By
Trading Desk
September 7, 2020
Health
Trump wants a COVID-19 vaccine by Election Day. But will one be ready?
By
Financial Writer
September 4, 2020
Most Popular
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
Senior Editor
Economy
One of the world’s most popular economists on why AI is ‘undoubtedly going to crash’: It’s built off ‘digital...
By
Market Analyst
Economy
Trump's retreats on tariffs have already wiped out $800 billion of expected deficit reduction, CBO estimates
By
Research Team